Clinical Trial 45973

Garden Grove, CA 92845


Summary:

The clinical trial is a Phase 2, double-blind, randomized, placebo controlled study in Major Depressive Disorder (MDD) participants currently treated with antidepressant therapy. The objective of the study is to assess CLE-100 for the treatment of MDD in participants currently treated with standard antidepressant therapy.



Criteria:
  • Male or female between 18 to 60 years of age
  • Primary diagnosis of MDD, without psychotic features according to DSM-5 and supported by the Mini International Neuropsychiatric Interview (MINI)
  • MADRS score of at least 18 at Screening
  • Treatment with stable dose of the current antidepressant therapy for at least 4 weeks for the current major depressive episode (MDE)
  • Body mass index (BMI) between 18 and 40 kg/m2, inclusive
  • Is able and competent to read and sign the informed consent form (ICF).


Qualified Participants May Receive:

Monetary compensation for participating.


Available At:

Collaborative Neuroscience Research, LLC

Garden Grove, CA 92845
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.